Are You Looking for a Top Momentum Pick? Why Si-Bone (SIBN) is a Great Choice
SI-BONE, Inc. (SIBN) Presents at 2026 UBS Global Healthcare Conference Transcript
SI-BONE (SIBN) Stock Rallies As Q3 Results Sharpen Profit Focus
SI-BONE, Inc. Q3 2026 Earnings Call Summary
UBS Maintains Buy on SI-BONE, Raises Price Target to $26
TD Cowen Maintains Buy on SI-BONE, Raises Price Target to $23
SI-BONE Inc (SIBN) Q3 2026 Earnings Call Highlights: Double-Digit Revenue Growth, Onyx Launch ...
Needham Maintains Buy on SI-BONE, Lowers Price Target to $26
SI-BONE (SIBN) Q3 2026 Earnings Call Transcript
Si-Bone: Q3 Earnings Snapshot
Does Reduced Q3 Loss Change The Bull Case For SI-BONE Stock (SIBN)?
SiBone Q3 Earnings Call Highlights
SI-BONE, Inc. (SIBN) Q3 2026 Earnings Call Transcript
Si-Bone (SIBN) Reports Q3 Loss, Tops Revenue Estimates
SI-BONE, Inc. Reports Financial Results for the Third Quarter 2026 and Reaffirms 2026 Revenue Guidance
SI-BONE Q3 2026 Earnings Call Transcript
SI-BONE Affirms FY2026 Sales Guidance of $231.000M-$233.000M vs $232.024M Est
SI-BONE Q3 EPS $(0.08) Beats $(0.13) Estimate, Sales $55.704M Beat $55.404M Estimate
SI-BONE (SIBN) Shares Just Moved, So What Is Going On?
SI-BONE To Present at UBS Global Healthcare Conference on November 10, 2026
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.